Clinical Trial: Study of the Effects of an Oral Nitric Oxide Supplement on Blood Pressure in Prehypertensive Adults
Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Study of the Effects of an Oral Nitric Oxide Supplement on Functional Capacity and Blood Pressure in Healthy Adults With Prehypertension
Brief Summary: Oral supplementation of Neo40(TM), a nitrate lozenge, will reduce blood pressure in healthy adults with clinical prehypertension.
Detailed Summary:
Sponsor: Neogenis Laboratories
Current Primary Outcome: Reduction in Systolic and Diastolic Blood Pressure Readings [ Time Frame: 30 days ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Improvement in Functional Capacity [ Time Frame: 30 days ]
Original Secondary Outcome: Same as current
Information By: Neogenis Laboratories
Dates:
Date Received: August 29, 2013
Date Started: January 2013
Date Completion:
Last Updated: September 4, 2013
Last Verified: September 2013